SOURCE: Accelrys


November 09, 2009 08:00 ET

Andrea R. Browning of Boeing to Present at AIChE® 2009 Conference on November 12th

SAN DIEGO, CA--(Marketwire - November 9, 2009) - Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific business intelligence software and services, today announced that Andrea R. Browning Ph.D., Boeing Research & Technology, a user of Accelrys Materials Studio™ modeling and simulation software, will be presenting at the 2009 AIChE Annual Meeting being held at the Gaylord Opryland Hotel in Nashville, Tennessee from November 8 to November 13, 2009.

In a session titled "Utilization of Molecular Simulations in Aerospace Materials: Simulation of Thermoset Resin/Graphite Interactions" scheduled for Thursday, November 12 at 8:30 a.m., Ms. Browning will describe the construction method used for thermoset resin modeling, and the simulation of graphite/resin interactions. This recent work in material simulations demonstrates that the future of aerospace materials development includes simulation tools. For the complete abstract, visit

The AIChE Annual Meeting is the premier educational forum for chemical engineers interested in innovation and professional growth. A wide range of subjects relevant to the latest research and newest technologies in emerging growth areas will be covered. The Accelrys exhibit in booth #18 will showcase the new features and enhancements found in Materials Studio 5.0, a single, integrated platform for advanced modeling and simulation. For more information on the conference, visit

About Accelrys, Inc.

Headquartered in San Diego, California, Accelrys develops scientific business intelligence software and solutions for the life sciences, energy, chemicals, aerospace, and consumer products industries. Customers include many Fortune 500 companies and other commercial entities, as well as academic and government entities. Accelrys has a vast portfolio of computer-aided design modeling and simulation offerings which assist customers in conducting scientific experiments 'in silico' in order to reduce the duration and cost of discovering and developing new drugs and materials. Its scientific business intelligence platform underlies the company's computer-aided design modeling and simulation offerings. The Accelrys platform can be used with both Accelrys and competitive products, as well as with customers' proprietary predictive science products. Its flexibility, ease-of-use and advanced chemical, text and image analysis and reporting capabilities enable customers to mine, aggregate, analyze and report scientific data from disparate sources, thereby better utilizing scientific data within their organizations. For more information about Accelrys, visit